Clinical Trials Logo

Clinical Trial Summary

This study evaluates an accelerated schedule of theta-burst stimulation for depressive symptoms in psychiatric inpatients. A small pilot study (n=22) will be carried out to demonstrate feasibility, using the FDA-approved stimulation site for depression treatment (L-DLPFC). Participants will be offered stimulation at the anterior cingulate cortex (ACC).


Clinical Trial Description

This study intends to investigate whether modifying stimulation parameters enables typical 6-8 week long rTMS protocols to be compressed to only five days. The influence of this accelerated protocol on the length of patient stay in the hospital will be investigated. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03601117
Study type Interventional
Source Stanford University
Contact
Status Completed
Phase N/A
Start date July 1, 2018
Completion date June 1, 2020

See also
  Status Clinical Trial Phase
Recruiting NCT06009523 - Effects of Transcranial Direct Current Stimulation (tDCS) in the Management of Suicidal Ideation N/A
Completed NCT02566980 - Biological Triggers of Depression in Pregnancy
Completed NCT04266288 - Effectiveness of Ketamine for Depression and Suicidal Ideation in the Emergency Department Phase 4
Recruiting NCT05437588 - Neural-Derived Plasma Exosomal MicroRNAs As Promising Novel Biomarkers for Suicidality and Treatment Outcome in Adolescents N/A
Recruiting NCT04760652 - Cognitive Behavioral Therapy Following Esketamine for Major Depression and Suicidal Ideation for Relapse Prevention N/A
Active, not recruiting NCT05930912 - Psychiatric Orders in Psychoanalytic Treatment of ASD
Not yet recruiting NCT06426342 - Development and Feasibility of a Metaverse-based Blended Online Intervention to Prevent Employees' Depression N/A
Recruiting NCT04572321 - Youth Depression and Suicide Research Network